作者：
Kento,Sawane [1]
;
Takahiro,Nagatake [2]
;
Koji,Hosomi [3]
;
So-Ichiro,Hirata [2]
;
Jun,Adachi [2]
;
Yuichi,Abe [2]
;
Junko,Isoyama [4]
;
Hidehiko,Suzuki [5]
;
Ayu,Matsunaga [6]
;
Satoshi,Fukumitsu [5]
;
Kazuhiko,Aida [2]
;
Takeshi,Tomonaga [2]
;
Makoto,Arita [1]
;
Jun,Kunisawa [7]
作者单位：
Nippon Flour Mills Co., Ltd., Innovation Center, Kanagawa 243-0041, Japan.
[1]
Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.
[2]
Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
[3]
Department of Microbiology and Immunology, Kobe University Graduate School of Medicine, Hyogo 650-0017, Japan.
[4]
Laboratory of Proteome Research, NIBIOHN, Osaka 567-0085, Japan.
[5]
Division of Molecular Diagnosis, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.
[6]
Collaborative Graduate School Program, University of Tsukuba, Ibaraki 305-8577, Japan.
[7]
Division of Physiological Chemistry and Metabolism, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo 105-8512, Japan.
[8]
Laboratory for Metabolomics, RIKEN Center for Integrative Medical Sciences, Kanagawa 230-0045, Japan.
[9]
Cellular and Molecular Epigenetics Laboratory, Graduate School of Medical Life Science, Yokohama City University, Kanagawa 230-0045, Japan.
[10]
Graduate School of Medicine and Graduate School of Dentistry, Osaka University, Osaka 565-0871, Japan.
[11]
Division of Mucosal Immunology, Department of Microbiology and Immunology and International Research and Development Center for Mucosal Vaccines, the Institute of Medical Science, the University of Tokyo, Tokyo 108-8639, Japan.
[12]
DOI
10.3390/nu11122868
PMID
31766714
发布时间
2020-06-25
换一批
换一批
